Videos uploaded by user “Proactive Investors Stocktube”
RNC Minerals unearths possibly biggest ever gold-rich stones in Australia
Mark Selby, President and CEO of RNC Minerals (TSE:RNX) spoke to Proactive London's Andrew Scott after announcing the first specimen slab from the top of the Father's Day Vein discovery area has been recovered at their Beta Hunt Mine in Western Australia. Selby says the slab, weighing around 90kg, is thought to contain approximately 1,000 ounces of gold. RNC reckons the gold-rich stones are among the biggest of their kind ever unearthed in Australia. 'We think we've made one of the great gold discoveries of this decade .. if not this century so far'', Selby says.
New Age Beverages offers healthy beverages, including Bob Marley-branded product line
New Age Beverages Corp (NASDAQ:NBEV) is targeting consumers looking for healthy beverage options, CEO Brent Willis tells Proactive Investors. The Colorado-based healthy functional beverage company was created in 2016 and is engaged in the development, marketing, sales, and distribution of beverages. Willis says the company owns patents on many of the beverages that it produces. Additionally, the company owns a significant intellectual property portfolio about the future state of the beverage industry. The company offers its products directly, as well as through store delivery distribution systems in the United States and internationally. One product is the Marley line of beverages, created in partnership with Bob Marley’s family. Within the Marley line, there are a range of products including Marley Mate and Mellow Mood. Willis says the company may consider acquisitions going forward and is looking to continue to expand its channels, including e-commerce, military, medical and food service channels.
CannTrust Holdings Inc approved to uplist to NYSE
CannTrust Holdings Inc (OTCMKTS:CNTTF) (TSE:TRST) CEO Peter Aceto tells Proactive Investors the Canadian-based cannabis company has been approved to list on the New York Stock Exchange, under the ticker CTST. Aceto says the company decided to uplist now because the company is increasing its product breadth as well as its global expansion. It's important for the future success of the company and its investor base to be as global as its patient and customer base, he says.
Invictus Energy advances Zimbabwe gas-condensate asset amid regulatory reforms
Invictus Energy Ltd (ASX:IVZ) managing director Scott Macmillan speaks to Proactive Investors about the oil and gas exploration company’s Cabora Bassa Project in northern Zimbabwe. “It’s a fantastic asset that we’ve picked up – it was previously explored by Mobil over 30 years ago and it’s been sitting dormant, locked up for the past 25 years. He continues, “the basin is very exciting and the portion of acreage that we’ve picked up contains the Mzarabani prospect. “It’s the largest undrilled seismically-defined structure in onshore Africa that’s got multi-trillion cubic feet potential.”
Seelos Therapeutics shares soar on acquisition of Parkinson's candidate license created at UCLA
Seelos Therapeutics Inc (NASDAQ:SEEL) CEO Dr. Raj Mehra tells Proactive Investors the company has acquired an exclusive license to the rights to a potential Parkinson’s disease therapy created by researchers at the University of California, Los Angeles. Mehra said the therapy, known as SLS-007, may slow the progression of Parkinson's disease. He said the company may soon perform studies in mice. Shares of the New York-based biotech rose more than 40% on Friday.
AgraFlora Organics International uses experience and facilities for a move to cannabis
AgraFlora Organics (CSE:AGRA) General Manager Ruben Houweling joined Steve Darling from Proactive Investors in the Vancouver office to talk about the merger of two companies to create AgraFlora. Houweling share details of their greenhouse in Delta, British Columbia, that is expected to be 350,000 square feet in Q-1 and growing. Houweling also pointed out another strong feature of this property will be their own power supply.
Graphite demand 'about to enter a period of rapid growth and improving prices'
Roskill's Kerry Satterthwaite and Suzanne Shaw discuss with Proactive Investors their Natural & Synthetic Graphite Global Industry, Markets & Outlook 2018 report. They say rapid growth in demand for natural flake graphite and synthetic graphite in the lithium-ion battery industry is now forecast to underpin total graphite demand growth of 5–7% per year between 2017 and 2027.
Ur-Energy  prepares to take on Putin after filing Section 232 Petition
Jeffrey Klenda, chief executive of Ur-Energy Inc (NYSEAMERICAN: URG) sat down with Proactive Investors at the 11th Annual LD Micro Main Event in Los Angeles, to update investors about the company’s uranium mineral properties. Ur-Energy engages in uranium mining and recovery operations. The Colorado company holds interests in at least 13 projects located in the US and its principal site is the Lost Creek project in Wyoming. "
Sativa Investments has "unique" market position for UK cannabis investors
Sativa Investments PLC's Geremy Thomas tells Proactive that the medicinal cannabis market has seen explosive growth all over the world, particularly in Vancouver, Canada. He adds that Sativa has a unique position in the UK market that allows UK investors to benefit from companies in regulated markets. Thomas says he has seen huge investment in medicinal cannabis businesses in the US and Canada, and expects a regulatory change around cannabis in the UK within the next 18 months to 2 years.
Admedus COO encouraged by initial results from Phase II herpes vaccine trial
Admedus Ltd's (ASX:AHZ) chief operating officer Julian Chick talks to Proactive Investors on the interim Herpes Simplex Virus Phase II clinical trial data. The blinded trial provided data from the first 20 patients to receive at least three vaccinations in the randomised, placebo–controlled HSV-2 vaccine Phase II study. Chick says he is “very encouraged” by the first set of results, which shows the study is “going in the right way and we are seeing what we want to see”.
Danakali “shovel-ready” at Colluli following execution of US$200m debt finance mandate
Danakali Ltd (ASX:DNK) (LON:DNK) executive chairman Seamus Cornelius updates Proactive Investors on the potash developer’s recent execution of a mandate to provide fully underwritten debt finance facilities of US$200M to fund and construct its Colluli Potash Project in Eritrea. “Given that we’re in Africa, if you were to take a market that is a specialist in funding African projects then that is probably London,” says Cornelius regarding Danakali’s recent AIM-listing. He continues, “getting the debt now with $200 million under the mandate letter, that helps us as well. “Where we are in terms of the project is we are shovel-ready, so as soon as we secure the full funding we will start construction – the construction will take two years and then we’ll be in production [in] 2021.”
'2019 is a very exciting year' for Sky and Space Global with nanosatellites set to  launch
Sky and Space Global Ltd (ASX:SAS) CEO Meir Moalem explains to Proactive Investors the global telecommunications company's strategy for creating and operating a commercial Low Earth Orbit nanosatellite network to service equatorial regions. The company has already signed 29 agreements with organisations internationally, with more expected to be announced ahead of the commercial launch, which is set to be fully realised before the end of 2020.
NetCents disrupting crypto world and soon to have technology in 60 countries
NetCents Technology (CSE:NC) Chief Revenue Officer Jenn Lowther joined Steve Darling from Proactive Investors in Vancouver to provide details about their cryptocurrency payment technology and some key deals the company has signed that will allow them to grow. Lowther also talked about a key part of their system that will allow merchants to settle in their own currency which will save time and money. Lowther also talked about what you can expect from NetCents in 2019.
Sirius Minerals PLC chief discusses DFS and York Potash financing
The long-awaited definitive feasibility study (DFS) for Sirius Minerals PLC's (LON:SXX) York Potash Project in North Yorkshire has underscored its huge potential. The report says its net present value today is US$15bn using a 10% discount rate. Managing Director, Chris Fraser, tells Proactive that the firm is “ready to go” on construction of the project, with the company now looking to how it will finance its development. He adds that the projects biggest competitive advantage is its margins, with the company expecting “around 70% margins up to 85% - and it’s very difficult to find projects or companies that come even close to those margins.”
InMed Pharmaceuticals disrupting cannabinoid space with biosynthesis technology
InMed Pharmaceuticals Inc (TSX:IN; OTCQX:IMLFF) Chief Business Officer Josh Blacher speaks with Proactive Investor's Christine Corrado about how the biopharma company is changing the game in the cannabinoid space. Blacher says the Vancouver based company, which specializes in developing therapeutics to treat a variety of diseases, is disrupting the space with its cannabinoid biosynthesis technology, which aims to manufacture any of the more than 90 variations of cannabinoids, resulting in products that are bio-identical to the naturally occurring cannabinoids in the cannabis plant.
Data443 Risk Mitigation's tech allows Facebook users to find own personal data on accounts
Data443 Risk Mitigation Inc (OTCMKTS:LDSR) CEO Jason Remillard had a chat with Proactive Investors at the MicroCap Conference in New York. The North Carolina-based software company, formerly known as LandStar Inc, develops cybersecurity products and services.
Namaste Technologies to launch its own version of a cannabis cafe in Toronto
Namaste Technologies Inc (TSXV:N) (OTCMKTS:NXTTF) CEO Sean Dollinger tells Proactive Investors that the cannabis company will be launching a new retail brand called "the Namaste Cafe", establishing its first location in Toronto, early next year. Dollinger says the Namaste Cafe will offer interactive cannabis educational opportunities, in addition to its full line of vaporizers and cannabis accessories, along with its H.E.A.L (healthy eating and living) branded foods products.
Glint reintroducing gold as money with launch of 'world first' payments app
Ben Davies, co-founder of Glint, spoke to Proactive as they launched their debit card and app (Glint Pay) which allows consumers to pay for goods and services with gold. The fintech group's teamed up with Lloyds Banking Group to create the app which allows people to load credit onto their card which can then be used to buy part of a physical piece of gold. Glint is regulated by the Financial Conduct Authority (FCA).
The Green Organic Dutchman to license dehydrating method for its organic cannabis
The Green Organic Dutchman Holdings (TSX:TGOD) (OTCQX:TGODF) CEO Brian Athaide tells Proactive Investors the company has formed a royalty-bearing commercial sublicense with tech company EnWave (TSX:ENW) and fellow cannabis company Tilray Inc (NASDAQ:TLRY). Athaide says TGOD's use of the new tech will promote consistency in the manufacturing, improve space efficiency by reducing the need for drying rooms, and quicken TGOD's time from harvest to sale.
How to Invest in Mining: Proactive Investors presents a beginners guide
In the first of a series of “How to” videos, Proactive Investors presents a beginners guide to investing in the mining sector. Featuring Amanda Van Dyke, Women in Mining; Jeremy Wrathall, Investec and Niall Pearson, Hybridan.
Tim Collins: Village Farms International's agricultural know-how sows success
Proactive Investors Contributor Tim Collins says Village Farms International Inc (OTCMKTS:VFFIF) (TSE:VFF) has the agricultural background to become a major player in the cannabis grow space. Collins says he doesn't think the stock, which was just approved to uplist to the Nasdaq and was trading north of $7 in the US, is expensive at the moment. He expects volatility for the entire cannabis industry.
Exro Technologies shaking up the energy storage industry with artificial intelligence
Exro Technologies Inc (OTCQB:EXROF) CEO Mark Godsy sat down with Proactive Investors at the LD Micro Conference in New York. The Vancouver-based company develops the technology behind rotating electrical machines, from cars and buses to cranes and wind turbines.
Bushveld Minerals 'still very undervalued' as earnings soar
Fortune Mojapelo, Bushveld Mineral Limited’s (LON:BMN) chief executive, believes the miner's first half numbers were good 'by any stretch'. He adds, however, that they were based on an average vanadium price of US$65 per tonne, whereas the current price is US$110 per tonne, which bodes well for the second half. Fundamentals for vanadium are also far stronger going forward than they have been in the past, he reckons. . Phase 3 expansion at the Vametco vanadium mine is commencing in earnest, while the group is also looking for new brownfield assets. A dividend policy should be in place by the end of the year, while a framework to highlight the value in the energy storage business is also planned. “The business is still very undervalued," believes Mojapelo.
ContraVir Pharmaceuticals CEO excited to get Hepatitis B drug to patients in new study
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) CEO James Sapirstein tells Proactive Investors the bio-pharmaceutical company has just announced a new formula of its Hepatitis B drug tenofovir exalidex (TXL) and can start delivering the drug to patients in a dose-range finding study, looking to be in Phase 3 trials sometime in the near future. Sapirstein also updated investors on the New Jersey based company's other Hepatitis B vaccine treatment called CRV-431, saying the FDA approved the company's investigational new drug application (IND).
VinaCapital investment chief on Vietnam’s growth opportunity
Andy Ho, chief investment officer of VinaCapital, says Vietnam’s fast growing economy is increasingly providing attractive opportunities for foreign investors and believes the country is on the path towards long-term sustainable growth. VinaCapital manages three closed-end funds trading on AIM, including the Vinacapital Vietnam Opp Fund (LON:VOF) which is migrating onto the main market of the London Stock Exchange. The vehicle invests in all asset classes, including listed and private equities, real estate, and bonds. The company’s VinaLand fund makes investments in residential, retail, hospitality and office sectors while its infrastructure vehicle puts money into transport and logistics, power & telecommunications.
MMJ PhytoTech positioned to become 'the Berkshire Hathaway of cannabis’
MMJ Phyto Tech Ltd (ASX:MMJ) chief executive officer Jason Conroy speaks to Proactive Investors about the cannabis investment company’s global portfolio of assets and strategic approach to the cannabis sector. “We invest up to about $5 million per investment across the cannabis value chain and across different stages of investment, either early-stage venture capital, seed capital, through to growth funding and pre-IPO funding. “I’ve been with the company for about 6 months now and my vision for the company is really just to turn it into the Berkshire Hathaway of cannabis. “Our model is built around backing very experienced management teams who understand the space but also understand old-fashioned things like operating cash-flow and how to calculate risk-adjusted returns and manage their business in an appropriate way.”
Harvest One’s recent deal with Shoppers Drug Mart another key to long term growth
Harvest One (CVE:HVT) Senior Vice President of Corporate and Public affairs Will Stewart joined Steve Daring from Proactive Investors Vancouver on Skype to talk about Harvest One’s recent deal with Shoppers Drug Mart and how the deal fits in to their overall plan moving forward. Stewart also provided an update on their Dream Water product that has seen a major overhaul and more distribution as well.
Oragenics is looking to lead the way in antibiotic research
Oragenics Inc ((NYSE American: OGEN) President and CEO Alan Joslyn joined Steve Darling from Proactive Investors in Los Angeles at the LD Micro Show with details about their bio tech company. The company is looking to accelerate the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat, and esophagus.
Fund Manager Marin Katusa shares his thoughts on Mining, Crypto and Cannabis
Best Selling author and fund manager Marin Katusa, from Katusa Research joined us in the Vancouver studio of Proactive Investors to share his thoughts on the state of the mining sector in BC and Canada. Katusa also had thoughts on Cannabis and what the legalization in October 17th in Canada will mean for investing. Katusa also shared something he is very high on and how it could be the next big thing, again.
The Green Organic Dutchman CFO says its Jamaican operation is growing
The Green Organic Dutchman Holdings Ltd (TSX:TGOD) (OTCQX:TGODF) CFO Sean Bovingdon tells Proactive Investors the organic cannabis company is seeing growth in its Jamaican operations. The Canadian cannabis company acquired a 49.2% stake in Jamaican cannabis company Epican last June, and Bovingdon talks about the highlights with Epican since then.
GeoVax Labs developing a therapy that potentially cures Hepatitis B
GeoVax Labs Inc. (OTCQB:GOVX) Chairman & CEO David Dodd sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The clinical-stage biotechnology company is developing human vaccines against infectious diseases using its Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform.
Nano One Materials signs two big deals with an eye on charging the future
Nano One Materials (CVE:NNO) CEO Dan Blondal dropped in the Vancouver studio of Proactive Investors to provide and update on two partnerships the company has entered in to. The biggest of the deal is with Chinese cathode producer Pulead Technology Industry. That deals will open Nano One up to the large Chinese market and beyond.
Emerald Health Therapeutics CFO confirms Canadian supply deals, calls US market 'tantalizing'
Emerald Health Therapeutics Inc (TSX-V:EMH) (OTCQX:EMHTF) CFO Rob Hill tells Proactive's Christine Corrado the Canadian cannabis company is in New York to present to investors at Proactive's CannaJam Forum. Hill says he believes US and Canadian investors alike are very excited about the cannabis space, and says while the US is a tantalizing market, Emerald is watching carefully how regulations around marijuana legalization changes before making any moves into the states. In Canada, Emerald Health has recently confirmed a cannabis supply agreement Ontario Cannabis Retail Corporation in anticipation of the adult-use market starting October 17, 2018.
EXRO Technologies looks to disrupt with Dynamic Power Management Technology
"Exro Technologies Inc (OTCQB:EXROF) CEO Mark Godsy sat down with Proactive Investors at the LD Micro Conference in New York. The Vancouver-based company develops the technology behind rotating electrical machines, from cars and buses to cranes and wind turbines."
Bulls, Bears & Brokers: Alto Capital's Tony Locantro hopes to lose housing market bet
Tony Locantro, stock market commentator and investment manager at Alto Capital, speaks to Danielle Doporto from Proactive Investors about a bet he has taken up with prominent Australian economist Stephen Koukoulas regarding the Australian housing market. The wager was initially extended to Martin North, principal of Digital Finance Analytics (DFA), following his appearance on a 60 Minutes Australia segment called 'Bricks and Slaughter.' Locantro stands to win A$15,000 from Koukoulas if Sydney or Melbourne or national house prices fall by more than 35% from their peak at any stage before the end of 2021. "I thought that was very attractive terms based on all my research and what I believe in; I can reassure people that there'll be no joy if I get anywhere near this because I think it's going to spell an absolute disaster for Australia," Locantro explains. Tony Tips the stock market as a better place for Aussies to be investing; watch our full video interview to hear which stocks he backs.
Zelda Therapeutics poised to 'value add all the way from clinical trials to the market'
Dr Richard Hopkins, the newly appointed managing director of Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF), talks Proactive Investors through the medical cannabis researcher's recent strategic review, and provides updates on the company's three current clinical trials. In its efforts to commercialise by bringing products to global markets as rapidly as possible, Zelda will focus on downstream integration, in contrast with many peer companies that are integrating upstream into cannabis cultivation. Clinical trials are still at the centre of Zelda's operations. Currently there are trials ongoing for: opioid reducing pain management with St Vincent’s Hospital in Melbourne; insomnia with one of Australia’s leading sleep research centres; and paediatric patients with autism at the Children's Hospital of Philadelphia in the US.
FAR Ltd turns to The Gambia as SNE oilfield approaches commercialisation milestone
FAR Ltd (ASX:FAR) managing director Cath Norman speaks to Proactive Investors about the oil and gas exploration company’s exciting advancements off the west coast of Africa. The company’s efforts are currently focused on The Gambia, and in particular on the Samo prospect. “Drilling an 800 million barrel prospect is large by any company standards... when you consider that at the moment we have a net 140 million barrels to our name in Senegal, and our market cap’s $500 million, it’s wonderful to think about what our market capitalisation could be after we’ve drilled this Gambian well and have access to maybe another 300 million barrels to FAR’s name. And we’ll have the results of that well by mid to late November at the latest, if we spud on October 1,” says Norman. FAR Ltd’s Senegalese operations are much more advanced, approaching a key milestone on the path to commercialisation. Norman explains, “we’ve got past the three principal hurdles of size, deliverability, and connectivity; so we understand everything about the oilfield now enough to progress to development. We are in a position today where we’ll be submitting the discoveries evaluation report to the government in about two weeks, which is a statement of commerciality, which I know a lot of our shareholders will be very pleased to see. And with that we’ll be progressively releasing some information about the final size for the development, and also the economics. The field will be developed in a phased development approach... we’ll be looking to get approval of our development plan by the end of this year, we’ll take the final investment decision in mid-2019, and then we’ve got an ambition to have first oil in about 2022.”
Ceres Power hits significant milestones with two key strategic partners
Phil Caldwell, chief executive of Ceres Power Holdings PLC (LON:CWR), tells Proactive London's Andrew Scott they're expecting full-year revenues to more than double after hitting two key commercial milestones with partners Bosch and Weichai Power. Caldwell says revenues and other operating income are expected to reach £15mln in the year, up from £7mln in 2017.
Here's what CannTrust needs to do to hit $10, says Bob Byrne
Proactive Investors contributor Bob Byrne says he believes CannTrust Holdings Inc (TSE:TRST) (OTCMKTS:CNTTF) is a cannabis company to watch. Byrne says the stock is cheap at about $6 compared to bigger cannabis stocks like Tilray (NASDAQ:TLRY ). Byrne says for the stock to move above $10, the Canntrust needs to uplist to a major US exchange and secure the necessary permits to complete the buildout of its Ontario, Canada facility.
Petroteq Energy CEO sees 'very aggressive' growth pattern in next four years
Petroteq Energy CEO David Sealock Interview tells Proactive Investors the integrated oil and gas company is facing strong growth as it continues to develop and implement proprietary technologies for the energy industry. According to Sealock, the environmentally safe and sustainable technology can be used for the extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. Sealock says the proprietary process produces zero greenhouse gas, zero waste and requires no high temperatures. Sealock says the company is currently fully funded, with a recent raise of $2.5mln in February and $3mln last month.
Graphene set to change everything says Versarien boss
From 3-D printing to sport, ‘wonder material’ graphene is set to change how we live according to Versarien PLC (LON:VRS) boss and founder Neil Ricketts. This year alone Versarien has started to work with former Olympian Kristan Bromley to develop graphene-enhanced skeleton boards, CT Engineering on aero parts and print specialist Absolute Engineering for graphene-based inks. Ricketts though, tells Proactive this is just the start as the understanding of these new materials and their uses is still at its very formative stages. For Versarien, having completed its IPO, raised funds and on track to break even, it all adds to a great place to be currently he explains.
Bulls, Bears & Brokers: Alto Capital's Tony Locantro updates on resources & housing
Tony Locantro, stock market commentator and investment manager at Alto Capital, catches up with Proactive Investors following attendance at the RIU Explorer's Conference For all of Tony's Tips and insights, watch our full video interview.
ITM Power CEO on ‘massive’ hydrogen infrastructure market
Graham Cooley, the chief executive of hydrogen fuel specialist ITM Power (LON:ITM), speaks about the ‘massive’ markets in energy storage and refuelling. Cooley explains the advantages of hydrogen vehicles over traditional plug-in electric cars and why ITM’s product is unique.
ReNeuron provides encouraging update to phase II eye disease trial
ReNeuron Group PLC (LON:RENE) said its cell-based therapy has shown signs that it can improve the vision of sufferers of a disease that causes blindness. Researchers in the US are carrying out a phase I/II clinical on people with retinitis pigmentosa. ReNeuron CFO Michael Hunt tells Proactive London why this early data is so encouraging after three patients in a group taking part in the phase II portion of the study were able on average able to read an additional three lines of on the standard ETDRS eye chart after receiving treatment. Doctors used human retinal progenitor cells developed by the AIM-listed life sciences company. Pre-clinical studies have shown they have the potential to preserve existing photoreceptors found in the retina, which could reduce or halt further deterioration of vision. In addition, these progenitor cells have been shown to mature into functional photoreceptors that could then help restore sight. The trial's principal investigator was Jason Comander from the Massachusetts Eye and Ear, who is also an assistant professor at the Harvard Medical School. He said: "It is exciting to move into a population of patients whose remaining vision and retinal architecture support the possibility of visual improvement and I am very much looking forward to obtaining additional results from this patient cohort and the next."
Eve & Co prepares to expand cannabis production facilities in Ontario
Eve & Co. (CVE:EVE) CEO Melinda Rombouts joined Steve Darling from Proactive Investors Vancouver on Skype to talk about their cannabis company located in Ontario. Their cultivation facility sits on a 32 acres property with annual production of 10,000 KG, but is expand to 50,000 this summer. Rombouts also told Proactive about their long term plans with company and which markets she sees at potential for sales growth.
Quadrise offers clarity on what investors can expect for 2019
Quadrise Fuels International PLC (LON:QFI) talks to Proactive Investors London about the new opportunities for business as the company puts a 'challenging year' behind them. Executive Chairman Mike Kirk has a reputation for being a plain speaker and says he likes to be honest with investors. After the November AGM Kirk repeats the answers to the tough questions on his company and gives new detail on why he believes 2019 will be so different. There's no doubt been question marks over Quadrise but Kirk says looking at the pedigree and experience of the board, investors can judge for themselves what 2019 will hold for the emulsion fuel business, particularly with the critical bringing forward of new regulations on emissions.
Peninsula Energy to become globally competitive uranium producer with low-pH ISR operation
Peninsula Energy Ltd (ASX:PEN) managing director & CEO Wayne Heili and non-executive chairman John Harrison update Proactive Investors on the uranium company’s recently completed feasibility study for its Lance Project in Wyoming, which supports the project’s transformation to a low-pH in-situ recovery (IRS) uranium operation. The study shows that Peninsula would become a globally competitive uranium producer by switching its uranium production method to low-pH ISR. “This is a low-risk, high-opportunity company,” Harrison says. He continues, “we have the ability to continue producing uranium in the manner that we are. We also have the ability – when we have the regulatory permits – to change it to a low-pH project which will only cost $5 million to convert the existing mine.”
CO2 GRO Inc revolutionizing outdoor plant growth strategies
CO2 GRO Inc (TSXV:GROW) CEO John Archibald updates Proactive's Christine Corrado at the MicroCap Conference in New York. The company is dedicated to increasing the growth of all indoor and outdoor value plants using our advanced CO2 technologies.
The Market Maker; what they do and how they make a market
ishareinfo.tv, in association with Proactiveinvestors, speaks to a market maker about pricing, the practice of going long and short on a stock and the effects of economic data and company news on the direction of shares.
EQTEC PLC's new CEO says improved project delivery can transform gas from waste specialist
Ian Price, EQTEC PLC’s (LON:EQT) new chief executive, explains the great thing about the business is that its technology combines waste destruction with energy generation. A strategic review highlighted the need to move from having a great a pipeline to delivering on projects. That has led to a consultant being appointed in Spain to provide the engineering design capability to move things forward. EQTEC’s waste to gas projects can range up to €100mln in value and once these start to be delivered Price is convinced the business can produce real shareholder value.